Bromide (Potassium / Sodium)
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | PO | Loading dose: 400-600 mg/kg/day divided q8-12h for 2-5 days; Maintenance: 30-40 mg/kg/day divided q12h or q24h | q12h or q24h | Duration: Long-term (lifelong for epilepsy) Notes: Therapeutic serum bromide concentration: 1-3 mg/mL (1000-3000 µg/mL). Adjust dose based on serum levels and clinical response. Monitor for bromide toxicity. |
| Cat | PO | Loading dose: 200-400 mg/kg/day divided q12h for 2-5 days; Maintenance: 20-30 mg/kg/day divided q12h or q24h | q12h or q24h | Duration: Long-term Notes: Cats have a shorter half-life and are more prone to bronchial irritation; use with caution. Therapeutic range: 1-2 mg/mL. |
| Horse | PO | 30-50 mg/kg/day divided q12h or q24h | q12h or q24h | Duration: Long-term Notes: Limited data; monitor serum levels and clinical response. |
Clinical Indications & Species Uses
- Anticonvulsant for seizure management in animals
- Adjunctive therapy for refractory epilepsy
- Maintenance treatment for idiopathic epilepsy
- Treatment of seizures not controlled by phenobarbital alone
- Adjunctive therapy for refractory epilepsy
- Treatment of seizures associated with inflammatory brain disease
- Treatment of epilepsy or seizures (rarely used)
- Adjunctive therapy for behavioral seizures
Pharmacology & Mechanism of Action
Drug Class: Anticonvulsant / Antiepileptic | Pharmacological Group: Halide salt
Mechanism of Action: Bromide is an inorganic halide that acts as an anticonvulsant by hyperpolarizing neuronal membranes. It competes with chloride ions for entry into neurons via GABA-A receptor chloride channels, enhancing GABA-mediated inhibitory neurotransmission. This results in an increased threshold for seizure activity and a reduction in the spread of epileptiform discharges. Bromide also affects the electrical activity of neurons by altering the resting membrane potential and reducing excitability.
Pharmacodynamics: Bromide produces a dose-dependent anticonvulsant effect. It has a wide therapeutic index and is effective in reducing the frequency and severity of seizures. The drug does not cause sedation at therapeutic doses, which is advantageous for long-term management. Its effects are primarily due to its action as a chloride mimetic, stabilizing neuronal membranes and enhancing inhibitory synaptic transmission.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Hypersensitivity to bromide
- Severe renal impairment
- Severe hepatic impairment (for potassium bromide, due to potassium load)
- Concurrent use with other nephrotoxic drugs
- Pregnancy (unless benefits outweigh risks)
- Use with caution in patients with renal disease, cardiac disease, or dehydration.
- Monitor serum bromide levels regularly (target 1-3 mg/mL in dogs, 1-2 mg/mL in cats).
- Bromide can cause gastrointestinal irritation; administer with food.
- In cats, bronchial irritation and coughing may occur; use with caution.
- Potassium bromide may cause hyperkalemia in patients with renal insufficiency.
- Sodium bromide may exacerbate congestive heart failure or hypertension due to sodium load.
- Abrupt withdrawal may precipitate seizures; taper dose gradually.
- Use in pregnant animals only if clearly needed; bromide crosses the placenta and may cause fetal harm.
Adverse Effects & Reactions
Common:
- Sedation (especially during loading)
- Vomiting
- Anorexia
- Constipation
- Polyuria
- Polydipsia
Serious / Severe:
- Bromide toxicity (bromism) with neurological signs (ataxia, tremors, paresis, coma)
- Pancreatitis (rare)
- Hyperkalemia (with potassium bromide)
- Sodium overload (with sodium bromide)
- Respiratory distress in cats (bronchial irritation)
Rare:
- Dermatitis
- Hepatotoxicity
- Renal toxicity
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Phenobarbital | Additive anticonvulsant effects; may allow lower doses of each drug. Monitor serum levels of both. | Moderate |
| Chloride-containing drugs (e.g., potassium chloride, sodium chloride) | High chloride intake increases renal excretion of bromide, reducing its efficacy. | Moderate |
| Diuretics (e.g., furosemide) | May increase bromide excretion, reducing serum levels. | Moderate |
| ACE inhibitors (e.g., enalapril) | May increase risk of hyperkalemia when used with potassium bromide. | Moderate |
| NSAIDs | Potential for increased nephrotoxicity; monitor renal function. | Mild |
Overdose & Toxicity Management
Signs of Toxicity:
- Vomiting
- Diarrhea
- Ataxia
- Tremors
- Sedation
- Coma
- Respiratory depression
- Cardiac arrhythmias (with potassium bromide)
Emergency Treatment Protocol: Discontinue drug. Administer intravenous fluids with sodium chloride to enhance bromide excretion. In severe cases, consider hemodialysis or peritoneal dialysis. Monitor serum electrolytes and neurological status. Supportive care including respiratory support if needed.
Food Animal Withdrawal Times
Not approved for use in food animals in the US. If used off-label, withdrawal times must be established by a veterinarian; due to long half-life, withdrawal may be prolonged (months).
Storage, Handling & Regulatory Information
Storage Temperature: Store at controlled room temperature (20-25°C, excursions 15-30°C).
Handling & Special Conditions: Keep container tightly closed. Protect from moisture. Compounded solutions should be stored according to pharmacy instructions.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Not FDA-approved for veterinary use; available as a compounded product or human-grade chemical.
Extra-Label (Off-Label) Use: Bromide is not FDA-approved for veterinary use; it is used extra-label under AMDUCA. For food animals, extra-label use is prohibited unless a valid VCPR and appropriate withdrawal times are established.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)